A plant micro RNA.

Phase of research

Potential treatment - clinical evidence

How it helps


Drug status

Natural product

Supporting references
Contradictory references
AI-suggested references
Clinical trials

General information

MIR2911 is a micro RNA that is present in honeysuckle decoction (Zhou et al., 2020).


Supporting references

Link Tested on Impact factor Notes Publication date
Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients
RNA Non-randomized controlled open trial Moderate severity
VERO E6 cells; patients 20.51

The plant miRNA in the form of exosomes collected from sera of healthy donors using honeysuckle decoction significantly inhibited viral replication in vitro. Patients with moderate COVID-19 infection receiving the miRNA in the form of honeysuckle decoction had significantly improved negative conversion rate and quicker became PCR-negative. Sample size: 6 + 69 control. Dosage: 10.5 pmol a day (30 g of dried honeysuckle).